Disclosure under SEBI Takeover Regulations

PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED CIN: U24239MH1991PLC059995 Registered Office: 11/12 Udyog Nagar, S.V. Road, Goregaon West, Mumbai 400 104. Tel: 022- 67607080 E-Mail- pbgil.250191@gmail.com/ gtblmumbai@gtbl.in 3rd July, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (East), Mumbai- 400051 Scrip Code 530199 Symbol: THEMISMED corp.relations@bseindia.com takeover@nse.co.in Gujarat Themis Biosyn Limited Block No. 69-c, GIDC Industrial Estate, Vapi 396195, Gujarat. cfoassist@themismedicare.com Dear Sir / Madam, Sub: Disclosure under Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Indirect Incumbrancer. With reference to the captioned subject, we enclose herewith the disclosure Pursuant to Regulation 31 / applicable provisions of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in respect of the creation of: a) a pledge over 25,24,245 equity shares, constituting 51% of the issued and paid-up share capital of Pharmaceutical Business Group (India) Limited ("PBGIL"); and b) a non-disposal undertaking over 21,57,855 equity shares, constituting 47.98% of the issued and paid-up share capital of PBGIL; by Vividhmargi Investments Private Limited (VIPL) in favour of CTL Trusteeship Limited, acting as Debenture Trustee, pursuant to the Pledge Agreement-cum-Non-Disposal Undertaking dated June 28, 2026, executed in connection with the Debenture Trust Deed dated June 25, 2026. As PBGIL holds 5,12,40,000 equity shares, constituting 47.02% of the equity share capital of Gujarat Themis Biosyn Limited (GTBL or Target), the aforesaid creation of pledge and non-disposal undertaking over the shares of PBGIL would result in an indirect encumbrance over 5,12,40,000 equity shares of the GTBL held by PBGIL. PBGIL is part of promoter group entity. PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED CIN: U24239MH1991PLC059995 Registered Office: 11/12 Udyog Nagar, S.V. Road, Goregaon West, Mumbai 400 104. Tel: 022- 67607080 E-Mail- pbgil.250191@gmail.com/ gtblmumbai@gtbl.in This is for your information and record please. Thanking you, Yours faithfully, For Pharmaceutical Business Group (India) Limited Mrs. Jayshree D. Patel Director Encl.: As above PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED CIN: U24239MH1991PLC059995 Registered Office: 11/12 Udyog Nagar, S.V. Road, Goregaon West, Mumbai 400 104. Tel: 022- 67607080 E-Mail- pbgil.250191@gmail.com/ gtblmumbai@gtbl.in Reg 31(1) creation of encumbrances / pledge by promoters (file with SE and TC, by Promoters within 7 working days from encumbrance) Disclosure by the Promoter(s) to the stock exchanges and to the Target Company for encumbrance of shares / invocation of encumbrance/ release of encumbrance, in terms of Regulation 31(1) and 31(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 Name of the Target Company (TC) Gujarat Themis Biosyn Limited 2 Names of the stock exchanges where the BSE Limited and National Stock Exchange of shares of the target company are listed India Limited 3 Date of reporting 3rdJuly, 2026 4 Name of the promoter or PAC on whose Indirect encumbrance on Shares in GTBL held shares encumbrance has been created by Pharmaceutical Business Group (India) /released/ invoked Limited, as explained in Note below. 5 Details of the creation of encumbrance: As mentioned below Sr. Name of promoter Promoter holding Promoter holding already (s) or PACs with him in the target company encumbered (2) Number % of total Number % of total (1) (2) (3) (4) (5) (6) 1 Pharmaceutical Business Group 5,12,40,000 47.02 25,50,000 4.98 (India) Limited (PBGIL)* PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED CIN: U24239MH1991PLC059995 Registered Office: 11/12 Udyog Nagar, S.V. Road, Goregaon West, Mumbai 400 104. Tel: 022- 67607080 E-Mail- pbgil.250191@gmail.com/ gtblmumbai@gtbl.in Sr. Details of events pertaining to encumbrance (3) Post event holding of encumbered shares $ (Creation) Type of Date of Type of Reasons Number % of Name of Number % of event creation/ encumbrance for share the entity in total (creation / release/ (pledge/ lien/ encumb- capital whose release / invocation of non disposal rance favor shares invocation) encumbrance undertaking/ ** encumbered others) *** (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) 1 Creation 29/06/2026 Indirect # As 5,12,40,000 47.02 CTL 5,12,40,000 47.02 encumbrance^ stated Trusteeship below Limited ^ Indirect encumbrance arising pursuant to (i) pledge over 25,24,245 equity shares and (ii) non-disposal undertaking over 21,57,855 equity shares of Pharmaceutical Business Group (India) Limited. This disclosure is being made keeping in view indirect encumbrance on shares of the Target. Pharmaceutical Business Group (India) Limited (PBGIL) holds 5,12,40,000 equity shares, constituting 47.02% of the equity share capital of Gujarat Themis Biosyn Limited (GTBL or Target). Vividhmargi Investment Private Limited (VIPL) has created encumbrance on its holding by way of; (i) pledge over 25,24,245 equity shares in PBGIL, and (ii) non-disposal undertaking over 21,57,855 equity shares in PBGIL. Accordingly, said encumbrance on the shares in PBGIL would result in indirect encumbrance on equity shares in GTBL held by PBGIL. # Pursuant to the Debenture Trust Deed and the Pledge Agreement-cum-Non-Disposal Undertaking. ${creation [(2)+(3)] / release [(2)-(3)]/ invocation [(1)-(3)]} (**) The names of all the promoters, their shareholding in the target company and their pledged shareholding as on the reporting date should appear in the table irrespective of whether they are reporting on the date of event or not. PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED CIN: U24239MH1991PLC059995 Registered Office: 11/12 Udyog Nagar, S.V. Road, Goregaon West, Mumbai 400 104. Tel: 022- 67607080 E-Mail- pbgil.250191@gmail.com/ gtblmumbai@gtbl.in (*) Total share capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC. Yours faithfully, For Pharmaceutical Business Group (India) Limited Mrs. Jayshree D. Patel Director